The National Times - BHP damages trial over Brazil mine disaster to open in 2027

BHP damages trial over Brazil mine disaster to open in 2027


BHP damages trial over Brazil mine disaster to open in 2027
BHP damages trial over Brazil mine disaster to open in 2027 / Photo: © AFP

Australian mining giant BHP will face trial before a British court from April next year to determine how much it must pay in damages to victims of a 2015 dam collapse in Brazil, lawyers said Wednesday.

Change text size:

In one of Brazil's worst environmental disasters, an iron-ore mine run by a firm co-owned by BHP unleashed a deluge of toxic mud into villages, fields, rainforest, rivers and the ocean, killing 19 people.

In November, the High Court in London found BHP "strictly liable" for the disaster following a mammoth trial, which could lead to hefty damages.

Victims of the disaster attended the hearing in London, where the court set a start date for the compensation trial of April 2027, with closing submissions scheduled for March 2028, according to lawyers for the plaintiffs.

"We are demanding what is owed to us," Brazilian Indigenous leader Marilda Lyrio de Oliveira, from Aracruz in the state of Espirito Santo, told AFP.

"We hope for a just outcome, because the impact was enormous, the crime was enormous.

"Many people are dying of cancer, something that didn't exist before," added Lyrio de Oliveira, as she stood alongside about a dozen other victims.

"We have physical and mental health problems because we can no longer carry out our former activities."

The law firm Pogust Goodhead, representing the plaintiffs, said in a statement that of the more than 600,000 people originally involved in the case, many had already reached "full and final" compensation settlements in Brazil, making them ineligible for further damages.

It said that lowered the number of plaintiffs in the case to 380,000.

BHP had earlier insisted the same, pointing out that it had already signed an agreement with the Brazilian authorities in 2024 to compensate victims.

It argued that "approximately 240,000 claimants" in the UK action should have their claims "discontinued".

- 'Shattered our lives' -

Dissatisfied with the proceedings in Brazil, the victims turned to the British courts two years ago, seeking £36 billion ($49 billion) in compensation.

At the time of the disaster, one of BHP's global headquarters was in Britain.

"The suffering was so immense that it shattered our lives and interrupted our dreams," Ana Paula Auxiliadora Alexandre, who lost her husband in the tragedy, told AFP.

"For 10 years, we fought for justice. The fact that a mega-corporation has been convicted here in England makes me think that the British justice system is more diligent than the Brazilian one," she added.

The trial at the High Court in London ran from October 2024 to March 2025.

The mine was managed by Samarco, co-owned by BHP and Brazilian miner Vale.

K.M.Thompson--TNT

Featured

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Change text size: